452 related articles for article (PubMed ID: 33210236)
21. Identification of a Transcription Factor Signature That Can Predict Breast Cancer Survival.
Fan C; Du J; Liu N
Comput Math Methods Med; 2021; 2021():2649123. PubMed ID: 33688372
[TBL] [Abstract][Full Text] [Related]
22. Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.
Xu Y; Shu D; Shen M; Wu Q; Peng Y; Liu L; Tang Z; Gao S; Wang Y; Liu S
J Immunol Res; 2022; 2022():9412119. PubMed ID: 35692496
[TBL] [Abstract][Full Text] [Related]
23. An immune cell infiltration-based immune score model predicts prognosis and chemotherapy effects in breast cancer.
Sui S; An X; Xu C; Li Z; Hua Y; Huang G; Sui S; Long Q; Sui Y; Xiong Y; Ntim M; Guo W; Chen M; Deng W; Xiao X; Li M
Theranostics; 2020; 10(26):11938-11949. PubMed ID: 33204321
[No Abstract] [Full Text] [Related]
24. A novel immune-related prognostic index for predicting breast cancer overall survival.
Yu X; Guo J; Zhou Q; Huang W; Xu C; Long X
Breast Cancer; 2021 Mar; 28(2):434-447. PubMed ID: 33146847
[TBL] [Abstract][Full Text] [Related]
25. Immune Landscape of Gastric Carcinoma Tumor Microenvironment Identifies a Peritoneal Relapse Relevant Immune Signature.
Zhang C; Li D; Yu R; Li C; Song Y; Chen X; Fan Y; Liu Y; Qu X
Front Immunol; 2021; 12():651033. PubMed ID: 34054812
[TBL] [Abstract][Full Text] [Related]
26. A novel tumor-associated neutrophil gene signature for predicting prognosis, tumor immune microenvironment, and therapeutic response in breast cancer.
Zhang J; Wang X; Zhang Z; Ma F; Wang F
Sci Rep; 2024 Mar; 14(1):5339. PubMed ID: 38438469
[TBL] [Abstract][Full Text] [Related]
27. Exploration of epithelial-mesenchymal transition-related lncRNA signature and drug sensitivity in breast cancer.
Li C; Zheng L; Xu G; Yuan Q; Di Z; Yang Y; Dong X; Hou J; Wu G
Front Endocrinol (Lausanne); 2023; 14():1154741. PubMed ID: 37538794
[TBL] [Abstract][Full Text] [Related]
28. Genome-wide screening and immune landscape suggest a potential-m6A-related lncRNA risk signature for predicting prognosis of melanoma.
Shen K; Wang H; Xue S; Wang L; Ren M; Gao Z; Wei C; Gu J
Ann Transl Med; 2022 Mar; 10(5):241. PubMed ID: 35402579
[TBL] [Abstract][Full Text] [Related]
29. A pyroptosis-related gene signature for prognostic and immunological evaluation in breast cancer.
Zhong Y; Peng F; Luo X; Wang X; Yang B; Tang X; Xu Z; Ren L; Wang Z; Peng C; Wang N
Front Oncol; 2022; 12():964508. PubMed ID: 36936274
[TBL] [Abstract][Full Text] [Related]
30. Identification and validation of a novel zinc finger protein-related gene-based prognostic model for breast cancer.
Ye M; Li L; Liu D; Wang Q; Zhang Y; Zhang J
PeerJ; 2021; 9():e12276. PubMed ID: 34721975
[TBL] [Abstract][Full Text] [Related]
31. A new 4-gene-based prognostic model accurately predicts breast cancer prognosis and immunotherapy response by integrating WGCNA and bioinformatics analysis.
Chen W; Kang Y; Sheng W; Huang Q; Cheng J; Pei S; Meng Y
Front Immunol; 2024; 15():1331841. PubMed ID: 38370403
[TBL] [Abstract][Full Text] [Related]
32. Development of a macrophages-related 4-gene signature and nomogram for the overall survival prediction of hepatocellular carcinoma based on WGCNA and LASSO algorithm.
Yang Z; Zi Q; Xu K; Wang C; Chi Q
Int Immunopharmacol; 2021 Jan; 90():107238. PubMed ID: 33316739
[TBL] [Abstract][Full Text] [Related]
33. Development and Validation of a Hypoxia-Related Signature for Predicting Survival Outcomes in Patients With Bladder Cancer.
Zhang F; Wang X; Bai Y; Hu H; Yang Y; Wang J; Tang Y; Ma H; Feng D; Li D; Han P
Front Genet; 2021; 12():670384. PubMed ID: 34122523
[TBL] [Abstract][Full Text] [Related]
34. Identification and validation of a five-gene prognostic signature based on bioinformatics analyses in breast cancer.
Du XJ; Yang XR; Wang QC; Lin GL; Li PF; Zhang WF
Heliyon; 2023 Feb; 9(2):e13185. PubMed ID: 36747547
[TBL] [Abstract][Full Text] [Related]
35. Tumor microenvironment-related multigene prognostic prediction model for breast cancer.
Hong K; Zhang Y; Yao L; Zhang J; Sheng X; Guo Y
Aging (Albany NY); 2022 Jan; 14(2):845-868. PubMed ID: 35060926
[TBL] [Abstract][Full Text] [Related]
36. Cuproptosis/ferroptosis-related gene signature is correlated with immune infiltration and predict the prognosis for patients with breast cancer.
Li J; Zhang W; Ma X; Wei Y; Zhou F; Li J; Zhang C; Yang Z
Front Pharmacol; 2023; 14():1192434. PubMed ID: 37521466
[No Abstract] [Full Text] [Related]
37. Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients.
Ma JY; Liu Q; Liu G; Peng S; Wu G
Aging (Albany NY); 2021 Jun; 13(12):16684-16695. PubMed ID: 34185683
[TBL] [Abstract][Full Text] [Related]
38. A six-gene-based signature for breast cancer radiotherapy sensitivity estimation.
Chen X; Zheng J; Zhuo ML; Zhang A; You Z
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33179733
[TBL] [Abstract][Full Text] [Related]
39. ATP2C2 Has Potential to Define Tumor Microenvironment in Breast Cancer.
Liu J; Wei Y; Wu Y; Li J; Sun J; Ren G; Li H
Front Immunol; 2021; 12():657950. PubMed ID: 33936088
[TBL] [Abstract][Full Text] [Related]
40. A 17-gene expression-based prognostic signature associated with the prognosis of patients with breast cancer: A STROBE-compliant study.
Qian JX; Yu M; Sun Z; Jiang AM; Long B
Medicine (Baltimore); 2020 Apr; 99(15):e19255. PubMed ID: 32282693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]